INVESTIGACIÓN

 

  Grupos de Investigación
  Unidades de Investigación
  Memoria Cientifíca
  Publicaciones
espacio

 

PUBLICACIONES

 

 


spacerTrabajos Publicados por Alberto Zambrano Duarte
spacer
  1. Prieto, I.; Zambrano, A.; Laso, J.; Aranda, A.; Samper, E.; Monsalve, M. "Early induction of senescence and immortalization in PGC-1α-deficient mouse embryonic fibroblasts.". Free Radic. Biol. Med.. 138(): 23-32. (2019). (PMID: 31029787).
    spacer

  2. Zambrano, A.; García-Carpizo, V.; Villamuera, R.; Aranda, A. "Thyroid hormone increases bulk histones expression by enhancing translational efficiency.". Mol. Endocrinol.. 29(1): 68-75. (2015). (PMID: 25422881).
    spacer

  3. Zambrano, A.; García-Carpizo, V.; Gallardo, M.E.; Villamuera, R.; Gómez-Ferrería, M.A.; Pascual, A.; Buisine, N.; Sachs, L.M.; Garesse, R.; Aranda, A. "The thyroid hormone receptor β induces DNA damage and premature senescence.". J. Cell Biol.. 204(1): 129-146. (2014). (PMID: 24395638).
    spacer

  4. Aranda, A.; Alonso-Merino, E.; Zambrano, A. "Receptors of thyroid hormones.". Pediatr Endocrinol Rev. 11(1): 2-13. (2013). (PMID: 24079074).
    spacer

  5. Morte, B.; Martínez, T.; Zambrano, A.; Pascual, A. "Monocyte-mediated regulation of genes by the amyloid and prion peptides in SH-SY5Y neuroblastoma cells.". Neurochem. Int.. 58(6): 613-619. (2011). (PMID: 21303680).
    spacer

  6. Wasylyk, C.; Zambrano, A.; Zhao, C.; Brants, J.; Abecassis, J.; Schalken, J.A.; Rogatsch, H.; Schaefer, G.; Pycha, A.; Klocker, H.; Wasylyk, B. "Tubulin tyrosine ligase like 12 links to prostate cancer through tubulin posttranslational modification and chromosome ploidy.". Int. J. Cancer. 127(11): 2542-2553. (2010). (PMID: 20162578).
    spacer

  7. Aranda, A.; Martínez-Iglesias, O.; Ruiz-Llorente, L.; García-Carpizo, V.; Zambrano, A. "Thyroid receptor: roles in cancer.". Trends Endocrinol. Metab.. 20(7): 318-324. (2009). (PMID: 19716314).
    spacer

  8. Cuesta, A.; Zambrano, A.; López, E.; Pascual, A. "Thyroid hormones reverse the UV-induced repression of APP in neuroblastoma cells.". FEBS Lett.. 583(14): 2401-2406. (2009). (PMID: 19563806).
    spacer

  9. González, L.; Zambrano, A.; Lazaro-Trueba, I.; Lopéz, E.; González, J.J.; Martín-Pérez, J.; Aranda, A. "Activation of the unliganded estrogen receptor by prolactin in breast cancer cells.". Oncogene. 28(10): 1298-1308. (2009). (PMID: 19169277).
    spacer

  10. Cuesta, A.; Zambrano, A.; Royo, M.; Pascual, A. "The tumour suppressor p53 regulates the expression of amyloid precursor protein (APP).". Biochem. J.. 418(3): 643-650. (2009). (PMID: 19049493).
    spacer

  11. Martínez-Iglesias, O.; Ruiz-Llorente, L.; Sánchez-Martínez, R.; García, L.; Zambrano, A.; Aranda, A. "Histone deacetylase inhibitors: mechanism of action and therapeutic use in cancer.". Clin Transl Oncol. 10(7): 395-398. (2008). (PMID: 18628067).
    spacer

  12. Sánchez-Martínez, R.; Zambrano, A.; Castillo, A.I.; Aranda, A. "Vitamin D-dependent recruitment of corepressors to vitamin D/retinoid X receptor heterodimers.". Mol. Cell. Biol.. 28(11): 3817-3829. (2008). (PMID: 18362166).
    spacer

  13. De los Santos, M.; Zambrano, A.; Sánchez-Pacheco, A.; Aranda, A. "Histone deacetylase inhibitors regulate retinoic acid receptor beta expression in neuroblastoma cells by both transcriptional and posttranscriptional mechanisms.". Mol. Endocrinol.. 21(10): 2416-2426. (2007). (PMID: 17622583).
    spacer

  14. De los Santos, M.; Zambrano, A.; Aranda, A. "Combined effects of retinoic acid and histone deacetylase inhibitors on human neuroblastoma SH-SY5Y cells.". Mol. Cancer Ther.. 6(4): 1425-1432. (2007). (PMID: 17431121).
    spacer

  15. Seghatoleslam, A.; Zambrano, A.; Millon, R.; Ganguli, G.; Argentini, M.; Cromer, A.; Abecassis, J.; Wasylyk, B. "Analysis of a novel human gene, LOC92912, over-expressed in hypopharyngeal tumours.". Biochem. Biophys. Res. Commun.. 339(1): 422-429. (2006). (PMID: 16300736).
    spacer

 

 

 

 

 

Instituto de Investigaciones Biomédicas "Alberto Sols"
C/Arturo Duperier 4. 28029 Madrid. (Spain)
Tel +(34) 91 585 4400 // Fax +(34) 91 558 4401
Email:Info